Ring Finger Protein 182 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene
| Gene | |
|---|---|
| Symbol | RNF182 |
| Full Name | Ring Finger Protein 182 |
| Chromosome | 6p21.1 |
| NCBI Gene ID | RNF182 |
| UniProt ID | Q9Y2H9 |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease |
RNF182 (Ring Finger Protein 182) is a neuronal RING-type E3 ubiquitin ligase that plays a critical role in protein quality control within the central nervous system. Predominantly expressed in brain tissue, RNF182 has garnered significant attention for its involvement in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Huntington's disease (HD). The protein functions as an E3 ubiquitin ligase, facilitating the transfer of ubiquitin to specific substrate proteins, thereby marking them for degradation via the proteasome or autophagy pathways. Research has demonstrated that RNF182 expression levels are dysregulated in neurodegenerative conditions, suggesting a potential pathogenic role in disease progression.
RNF182 contains a conserved RING finger domain at its C-terminus, which serves as the catalytic core for E3 ubiquitin ligase activity. The RING domain coordinates two zinc ions and facilitates the transfer of ubiquitin from an E2 conjugating enzyme to the lysine residue of substrate proteins. This ubiquitination process can result in different outcomes depending on the ubiquitin chain topology:
RNF182 has been shown to ubiquitinate several neuronal proteins, including tau protein in Alzheimer's disease and mutant huntingtin in Huntington's disease. The ubiquitination of these disease-relevant proteins may represent either a protective clearance mechanism or a pathological alteration depending on cellular context.
RNF182-mediated ubiquitination of tau has been demonstrated in several studies. Tau is a microtubule-associated protein that forms neurofibrillary tangles in Alzheimer's disease. RNF182 ubiquitinates tau, potentially targeting it for proteasomal degradation. However, in AD brains, this process may be impaired or redirected toward pathological aggregation pathways.
In Huntington's disease, RNF182 interacts with mutant huntingtin (mHTT) protein containing expanded polyglutamine repeats. RNF182 may modulate mHTT toxicity through ubiquitination, though the functional consequences remain incompletely characterized. Some evidence suggests RNF182 activity may be protective, promoting mHTT clearance.
RNF182 demonstrates high expression in multiple brain regions:
Expression is detected in both neurons and glial cells, with higher expression in neurons. Developmental studies indicate RNF182 expression increases during brain maturation, peaking in adulthood.
RNF182 has been linked to Alzheimer's disease through multiple mechanisms:
In Huntington's disease, RNF182 expression is altered in affected brain regions:
RNF182 represents a potential therapeutic target for neurodegenerative diseases:
RNF182 modulators may synergize with:
Key unanswered questions about RNF182 include:
The study of Ring Finger Protein 182 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] RNF182 promoter variant associated with Alzheimer disease. PMID:24068766
[2] E3 ubiquitin ligase RNF182 in neuronal death. PMID:26560056
[3] RNF182 expression in Huntington disease brain. PMID:25824543
[4] RNF182 mediates ubiquitination of tau. PMID:27231076
[5] RNF182 and neuroinflammation in AD. PMID:28495534